Intermolecular Inc Issues Q3 2013 Guidance Below Analysts' Estimates


Thursday, 25 Jul 2013 04:10pm EDT 

Intermolecular Inc announced that for the third quarter of 2013, it projects revenue in the range of $15.0 to $16.0 million. This revenue projection includes $14.2 million from reported backlog as of June 30, 2013. Non-GAAP net loss, excluding stock-based compensation expense, is projected between a non-GAAP net loss of $(2.0) million and $(1.0) million, or between $(0.04) per share to $(0.02) per share (EPS), on approximately 45 million basic shares outstanding. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $17.7 million, net income of $0.7 million and EPS of $0.03 for the third quarter of 2013. 

Company Quote

1.92
 --
22 May 2015